Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
Conditions
Interventions
Intervention1: Codeine and acetaminophen fixed drug combination: Fixed drug combination will
be given, three times a day for a period of 2 weeks. Doses will be increased according to response up to
Sponsors
BASAVATRARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE
Eligibility
Inclusion criteria
Inclusion criteria: Adult who are aged more than 18 years who have lung cancer irrespective of the stage who consent for the study. Pain score should be less than 7 in NRS and the patient should have no cognitive impairment
Exclusion criteria
Exclusion criteria: Patients with cancer whose age is less than 18 and those with lung cancer who do not consent for the study. Previous opioid users will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adequate pain relief of more than or equal to 60 percentage with the initiation of fixed dose combination of drugsTimepoint: The patients will be interviewed after the first day and on the 7th day and then on the 14th day of drug initiation | — |
Secondary
| Measure | Time frame |
|---|---|
| SIDE EFFECT ASSESSMENTTimepoint: DAY ONE. DAY 7, DAY 14 | — |
Countries
India
Contacts
Public ContactPRANEETH SUVVARI
BASAVATRARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE
Outcome results
None listed